BackgroundFull-thickness articular cartilage injury of the knee is a major cause of disability. The aim of this study is to assess the outcome of patients treated with differentiated to chondrocytes bone marrow mesenchymal stem cells (BM-MSCs) cultured on a collagen type I/III (Chondro-Gide (R)) scaffold. The secondary aim was to confirm the absence of adverse events.MethodsFifteen patients (19 knees) with symptomatic full-thickness cartilage defects of the knee were enrolled. Bone marrow was harvested from the iliac crest, BM-MSCs were prepared, and expanded cells were grown in a standard medium or in a standard culture medium containing TGF-beta. BM-MSCs differentiated to chondrocytes were seeded in a porcine collagen type I/III scaffold (Chondro-Gide (R)) and cultured in TGF-beta containing media. After 4 weeks, the membrane was sutured on the cartilage defect. All patients underwent plain radiographs (antero-posterior, lateral, and axial view of the patella) and MRI of the affected knee. The Oxford knee score, the Lyhsolm scale, and the VAS score were administered to all patients. At final follow-up a MRI for the study of articular cartilage was undertaken.ResultsThe mean size of the cartilage lesions was 20 x 17 mm (range, 15 x 10 mm-30 x 30 mm). At final follow-up, the median Oxford knee score and Lyhsolm scale scores significantly improved from 29 (range 12-39; SD 7.39) to 45 (range 24-48; SD 5.6) and from 55.5 (range 25-81; SD 17.7) to 94.5 (58-100; SD 10.8), respectively. Pain, according to the VAS score, significantly improved. Sixty percent of patients reported their satisfaction as excellent, 20% as good, 14% as fair, and 1 patient as poor.ConclusionThe treatment of full-thickness chondral injuries of the knee with differentiated to chondrocytes BM-MSCs and Chondro-Gide (R) scaffold showed encouraging outcomes. Further studies involving more patients, and with longer follow-up, are required to evaluate the effectiveness of the treatment and the long-term results.

BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee / Mardones, Rodrigo; Giai Via, Alessio; Pipino, Gennaro; Jofre, Claudio M; Muñoz, Sara; Narvaez, Edgar; Maffulli, Nicola. - In: JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH. - ISSN 1749-799X. - 15:1(2020), pp. 1-11. [10.1186/s13018-020-01852-x]

BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee

Maffulli, Nicola
2020

Abstract

BackgroundFull-thickness articular cartilage injury of the knee is a major cause of disability. The aim of this study is to assess the outcome of patients treated with differentiated to chondrocytes bone marrow mesenchymal stem cells (BM-MSCs) cultured on a collagen type I/III (Chondro-Gide (R)) scaffold. The secondary aim was to confirm the absence of adverse events.MethodsFifteen patients (19 knees) with symptomatic full-thickness cartilage defects of the knee were enrolled. Bone marrow was harvested from the iliac crest, BM-MSCs were prepared, and expanded cells were grown in a standard medium or in a standard culture medium containing TGF-beta. BM-MSCs differentiated to chondrocytes were seeded in a porcine collagen type I/III scaffold (Chondro-Gide (R)) and cultured in TGF-beta containing media. After 4 weeks, the membrane was sutured on the cartilage defect. All patients underwent plain radiographs (antero-posterior, lateral, and axial view of the patella) and MRI of the affected knee. The Oxford knee score, the Lyhsolm scale, and the VAS score were administered to all patients. At final follow-up a MRI for the study of articular cartilage was undertaken.ResultsThe mean size of the cartilage lesions was 20 x 17 mm (range, 15 x 10 mm-30 x 30 mm). At final follow-up, the median Oxford knee score and Lyhsolm scale scores significantly improved from 29 (range 12-39; SD 7.39) to 45 (range 24-48; SD 5.6) and from 55.5 (range 25-81; SD 17.7) to 94.5 (58-100; SD 10.8), respectively. Pain, according to the VAS score, significantly improved. Sixty percent of patients reported their satisfaction as excellent, 20% as good, 14% as fair, and 1 patient as poor.ConclusionThe treatment of full-thickness chondral injuries of the knee with differentiated to chondrocytes BM-MSCs and Chondro-Gide (R) scaffold showed encouraging outcomes. Further studies involving more patients, and with longer follow-up, are required to evaluate the effectiveness of the treatment and the long-term results.
2020
articular cartilage; cartilage injury; collagen scaffold; knee; mesenchymal stem cells
01 Pubblicazione su rivista::01a Articolo in rivista
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee / Mardones, Rodrigo; Giai Via, Alessio; Pipino, Gennaro; Jofre, Claudio M; Muñoz, Sara; Narvaez, Edgar; Maffulli, Nicola. - In: JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH. - ISSN 1749-799X. - 15:1(2020), pp. 1-11. [10.1186/s13018-020-01852-x]
File allegati a questo prodotto
File Dimensione Formato  
Mardones_BM-MSCs-differentiated-tochondrocytes_2020 .pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 10.29 MB
Formato Adobe PDF
10.29 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1694936
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 7
social impact